Literature DB >> 3789890

Comparative effect of tropolone and diosmin on venous COMT and sympathetic activity in rat.

C Boudet, L Peyrin.   

Abstract

The ability of diosmin to inhibit venous catechol-O-methyltransferase (COMT) activity was studied comparing it with tropolone in rat superior mesenteric vein (MV), inferior vena cava (IVC) and saphenous vein (SV). Diosmin inhibited COMT activity in the mesenteric vein after 200 and 400 mg/kg i.p., but only at 400 mg/kg in IVC. The COMT inhibitory effect of diosmin (400 mg/kg) was smaller than that of tropolone (50 mg/kg). Furthermore, diosmin, but not tropolone, increased urinary normetanephrine (NMN) excretion (+56%) at 400 mg/kg and that of 3-methoxy 4-hydroxyphenylglycol (MHPG) in a dose-dependent way, thus suggesting that diosmin may exert an activating effect on sympathetic activity. Both mechanism--local inhibition of COMT and enhanced sympathetic activity--may contribute to increase NE levels in the synaptic clefts of the vascular wall and explain the venoconstrictor effect of this drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789890

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  6 in total

Review 1.  [Systemic therapy of chronic venous diseases].

Authors:  S Reich; P Altmeyer; M Stücker
Journal:  Hautarzt       Date:  2006-01       Impact factor: 0.751

2.  Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2011-04-16       Impact factor: 4.268

Review 3.  Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy.

Authors:  Armando Mansilha; Joel Sousa
Journal:  Int J Mol Sci       Date:  2018-06-05       Impact factor: 5.923

Review 4.  Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.

Authors:  Michèle Cazaubon; Jean-Patrick Benigni; Marcio Steinbruch; Violaine Jabbour; Christelle Gouhier-Kodas
Journal:  Vasc Health Risk Manag       Date:  2021-09-16

5.  Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Vessel Plus       Date:  2021-05-29

6.  Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports.

Authors:  Giulia Milano; Silvia Leone; Carmen Fucile; Maria Laura Zuccoli; Andrea Stimamiglio; Antonietta Martelli; Francesca Mattioli
Journal:  J Med Case Rep       Date:  2014-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.